Covid-19 Impact on Global mRNA Vaccines Market Size, Status and Forecast 2020-2026

Covid-19 Impact on Global mRNA Vaccines Market Size, Status and Forecast 2020-2026

May 2020 QYResearch ICT94 Pages Price :
$ 3900
This report focuses on the global mRNA Vaccines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the mRNA Vaccines development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
MODERNA
Pfizer
Zydus Cadila
Fosun Pharmaceutical
CureVac
Stemirna
...

Market segment by Type, the product can be split into
Being Developed
Preclinical
Clinical I
Clinical II
Market segment by Application, split into
COVID-19
Cancer
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global mRNA Vaccines status, future forecast, growth opportunity, key market and key players.
To present the mRNA Vaccines development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of mRNA Vaccines are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by mRNA Vaccines Revenue
1.4 Market Analysis by Type
1.4.1 Global mRNA Vaccines Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Being Developed
1.4.3 Preclinical
1.4.4 Clinical I
1.4.5 Clinical II
1.5 Market by Application
1.5.1 Global mRNA Vaccines Market Share by Application: 2020 VS 2026
1.5.2 COVID-19
1.5.3 Cancer
1.5.4 Infectious Disease Treatment MRNA Vaccine
1.5.5 Infection Prevention MRNA Vaccine
1.6 Coronavirus Disease 2019 (Covid-19): mRNA Vaccines Industry Impact
1.6.1 How the Covid-19 is Affecting the mRNA Vaccines Industry
1.6.1.1 mRNA Vaccines Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and mRNA Vaccines Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for mRNA Vaccines Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 mRNA Vaccines Market Perspective (2015-2026)
2.2 mRNA Vaccines Growth Trends by Regions
2.2.1 mRNA Vaccines Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 mRNA Vaccines Historic Market Share by Regions (2018-2019)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Competition Landscape by Key Players
3.1 mRNA Vaccines Revenue by Players (2019-2020)
3.2 mRNA Vaccines Key Players Head office and Area Served
3.3 Key Players mRNA Vaccines Product/Solution/Service
3.4 Date of Enter into mRNA Vaccines Market
3.5 Key Players mRNA Vaccines Funding/Investment Analysis
3.6 Global Key Players mRNA Vaccines Valuation & Market Capitalization
3.7 Mergers & Acquisitions, Expansion Plans

4 Global mRNA Vaccines Market Size by Type (2019-2026)

5 Global mRNA Vaccines Market Size by Application (2019-2026)

6 North America
6.1 North America mRNA Vaccines Market Forecast (2019-2026)
6.2 mRNA Vaccines Key Players in North America (2019-2020)
6.3 North America mRNA Vaccines Market Size by Type (2015-2020)
6.4 North America mRNA Vaccines Market Size by Application (2015-2020)

7 Europe
7.1 Europe mRNA Vaccines Market Forecast (2019-2026)
7.2 mRNA Vaccines Key Players in Europe (2019-2020)
7.3 Europe mRNA Vaccines Market Size by Type (2015-2020)
7.4 Europe mRNA Vaccines Market Size by Application (2015-2020)

8 China
8.1 China mRNA Vaccines Market Forecast (2019-2026)
8.2 mRNA Vaccines Key Players in China (2019-2020)
8.3 China mRNA Vaccines Market Size by Type (2015-2020)
8.4 China mRNA Vaccines Market Size by Application (2015-2020)

9 Japan
9.1 Japan mRNA Vaccines Market Forecast (2019-2026)
9.2 mRNA Vaccines Key Players in Japan (2019-2020)
9.3 Japan mRNA Vaccines Market Size by Type (2015-2020)
9.4 Japan mRNA Vaccines Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia mRNA Vaccines Market Forecast (2019-2026)
10.2 mRNA Vaccines Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia mRNA Vaccines Market Size by Type (2015-2020)
10.4 Southeast Asia mRNA Vaccines Market Size by Application (2015-2020)

11 India
11.1 India mRNA Vaccines Market Forecast (2019-2026)
11.2 mRNA Vaccines Key Players in India (2019-2020)
11.3 India mRNA Vaccines Market Size by Type (2015-2020)
11.4 India mRNA Vaccines Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America mRNA Vaccines Market Forecast (2019-2026)
12.2 mRNA Vaccines Key Players in Central & South America (2019-2020)
12.3 Central & South America mRNA Vaccines Market Size by Type (2015-2020)
12.4 Central & South America mRNA Vaccines Market Size by Application (2015-2020)

13Key Players Profiles
13.1 MODERNA
13.1.1 MODERNA Company Details
13.1.2 MODERNA Business Overview and Its Total Revenue
13.1.3 MODERNA mRNA Vaccines Introduction
13.1.4 MODERNA Revenue in mRNA Vaccines Business (2019-2020))
13.1.5 MODERNA Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview and Its Total Revenue
13.2.3 Pfizer mRNA Vaccines Introduction
13.2.4 Pfizer Revenue in mRNA Vaccines Business (2019-2020))
13.2.5 Pfizer Recent Development
13.3 Zydus Cadila
13.3.1 Zydus Cadila Company Details
13.3.2 Zydus Cadila Business Overview and Its Total Revenue
13.3.3 Zydus Cadila mRNA Vaccines Introduction
13.3.4 Zydus Cadila Revenue in mRNA Vaccines Business (2019-2020))
13.3.5 Zydus Cadila Recent Development
13.4 Fosun Pharmaceutical
13.4.1 Fosun Pharmaceutical Company Details
13.4.2 Fosun Pharmaceutical Business Overview and Its Total Revenue
13.4.3 Fosun Pharmaceutical mRNA Vaccines Introduction
13.4.4 Fosun Pharmaceutical Revenue in mRNA Vaccines Business (2019-2020))
13.4.5 Fosun Pharmaceutical Recent Development
13.5 CureVac
13.5.1 CureVac Company Details
13.5.2 CureVac Business Overview and Its Total Revenue
13.5.3 CureVac mRNA Vaccines Introduction
13.5.4 CureVac Revenue in mRNA Vaccines Business (2019-2020))
13.5.5 CureVac Recent Development
13.6 Stemirna
13.6.1 Stemirna Company Details
13.6.2 Stemirna Business Overview and Its Total Revenue
13.6.3 Stemirna mRNA Vaccines Introduction
13.6.4 Stemirna Revenue in mRNA Vaccines Business (2019-2020))
13.6.5 Stemirna Recent Development

14 Market Dynamics
14.1 Drivers
14.2 Challenges
14.3 Porters Five Forces Analysis
14.4 Market Ecosystem and Value Chain Analysis

15 Key Findings in This Report
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Table

List of Tables
Table 1. mRNA Vaccines Key Market Segments
Table 2. Key Players Covered: Ranking by mRNA Vaccines Revenue
Table 3. Ranking of Global Top mRNA Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global mRNA Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Being Developed
Table 6. Key Players of Preclinical
Table 7. Key Players of Clinical I
Table 8. Key Players of Clinical II
Table 9. COVID-19 Impact Global Market: (Four mRNA Vaccines Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for mRNA Vaccines Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for mRNA Vaccines Players to Combat Covid-19 Impact
Table 14. Global mRNA Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global mRNA Vaccines Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global mRNA Vaccines Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global mRNA Vaccines Market Share by Regions 2019-2026
Table 18. Market Top Trends
Table 19. Market Use Cases
Table 20. Global mRNA Vaccines Revenue by Players (2019-2020) (Million US$)
Table 21. Global mRNA Vaccines Market Share by Players (2019-2020)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players mRNA Vaccines Product Solution and Service
Table 24. Date of Enter into mRNA Vaccines Market
Table 25. Global Key Players mRNA Vaccines Funding/Investment Analysis (Million USD)
Table 26. Global Key Players mRNA Vaccines Valuation & Market Capitalization (Million USD)
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global mRNA Vaccines Market Size by Type (2019-2026) (Million US$)
Table 29. Global mRNA Vaccines Market Size Share by Type (2019-2026)
Table 30. Global mRNA Vaccines Market Size by Application (2019-2026) (Million US$)
Table 31. Global mRNA Vaccines Market Size Share by Application (2019-2026)
Table 32. North America Key Players mRNA Vaccines Revenue (2019-2020) (Million US$)
Table 33. North America Key Players mRNA Vaccines Market Share (2019-2020)
Table 34. North America mRNA Vaccines Market Size by Type (2019-2026) (Million US$)
Table 35. North America mRNA Vaccines Market Share by Type (2019-2026)
Table 36. North America mRNA Vaccines Market Size by Application (2019-2026) (Million US$)
Table 37. North America mRNA Vaccines Market Share by Application (2019-2026)
Table 38. Europe Key Players mRNA Vaccines Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players mRNA Vaccines Market Share (2019-2020)
Table 40. Europe mRNA Vaccines Market Size by Type (2019-2026) (Million US$)
Table 41. Europe mRNA Vaccines Market Share by Type (2019-2026)
Table 42. Europe mRNA Vaccines Market Size by Application (2019-2026) (Million US$)
Table 43. Europe mRNA Vaccines Market Share by Application (2019-2026)
Table 44. China Key Players mRNA Vaccines Revenue (2019-2020) (Million US$)
Table 45. China Key Players mRNA Vaccines Market Share (2019-2020)
Table 46. China mRNA Vaccines Market Size by Type (2019-2026) (Million US$)
Table 47. China mRNA Vaccines Market Share by Type (2019-2026)
Table 48. China mRNA Vaccines Market Size by Application (2019-2026) (Million US$)
Table 49. China mRNA Vaccines Market Share by Application (2019-2026)
Table 50. Japan Key Players mRNA Vaccines Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players mRNA Vaccines Market Share (2019-2020)
Table 52. Japan mRNA Vaccines Market Size by Type (2019-2026) (Million US$)
Table 53. Japan mRNA Vaccines Market Share by Type (2019-2026)
Table 54. Japan mRNA Vaccines Market Size by Application (2019-2026) (Million US$)
Table 55. Japan mRNA Vaccines Market Share by Application (2019-2026)
Table 56. Southeast Asia Key Players mRNA Vaccines Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players mRNA Vaccines Market Share (2019-2020)
Table 58. Southeast Asia mRNA Vaccines Market Size by Type (2019-2026) (Million US$)
Table 59. Southeast Asia mRNA Vaccines Market Share by Type (2019-2026)
Table 60. Southeast Asia mRNA Vaccines Market Size by Application (2019-2026) (Million US$)
Table 61. Southeast Asia mRNA Vaccines Market Share by Application (2019-2026)
Table 62. India Key Players mRNA Vaccines Revenue (2019-2020) (Million US$)
Table 63. India Key Players mRNA Vaccines Market Share (2019-2020)
Table 64. India mRNA Vaccines Market Size by Type (2019-2026) (Million US$)
Table 65. India mRNA Vaccines Market Share by Type (2019-2026)
Table 66. India mRNA Vaccines Market Size by Application (2019-2026) (Million US$)
Table 67. India mRNA Vaccines Market Share by Application (2019-2026)
Table 68. Central & South America Key Players mRNA Vaccines Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players mRNA Vaccines Market Share (2019-2020)
Table 70. Central & South America mRNA Vaccines Market Size by Type (2019-2026) (Million US$)
Table 71. Central & South America mRNA Vaccines Market Share by Type (2019-2026)
Table 72. Central & South America mRNA Vaccines Market Size by Application (2019-2026) (Million US$)
Table 73. Central & South America mRNA Vaccines Market Share by Application (2019-2026)
Table 74. MODERNA Company Details
Table 75. MODERNA Business Overview
Table 76. MODERNA Product
Table 77. Company Description and Business Overview
Table 78. MODERNA mRNA Vaccines Product
Table 79. MODERNA Revenue in mRNA Vaccines Business 2019 and 2020 (Million US$)
Table 80. MODERNA Recent Development
Table 81. Pfizer Company Details
Table 82. Pfizer Business Overview
Table 83. Pfizer Product
Table 84. Company Description and Business Overview
Table 85. Pfizer mRNA Vaccines Product
Table 86. Pfizer Revenue in mRNA Vaccines Business 2019 and 2020 (Million US$)
Table 87. Pfizer Recent Development
Table 88. Zydus Cadila Company Details
Table 89. Zydus Cadila Business Overview
Table 90. Zydus Cadila Product
Table 91. Company Description and Business Overview
Table 92. Zydus Cadila mRNA Vaccines Product
Table 93. Zydus Cadila Revenue in mRNA Vaccines Business 2019 and 2020 (Million US$)
Table 94. Zydus Cadila Recent Development
Table 95. Fosun Pharmaceutical Company Details
Table 96. Fosun Pharmaceutical Business Overview
Table 97. Fosun Pharmaceutical Product
Table 98. Company Description and Business Overview
Table 99. Fosun Pharmaceutical mRNA Vaccines Product
Table 100. Fosun Pharmaceutical Revenue in mRNA Vaccines Business 2019 and 2020 (Million US$)
Table 101. Fosun Pharmaceutical Recent Development
Table 102. CureVac Company Details
Table 103. CureVac Business Overview
Table 104. CureVac Product
Table 105. Company Description and Business Overview
Table 106. CureVac mRNA Vaccines Product
Table 107. CureVac Revenue in mRNA Vaccines Business 2019 and 2020 (Million US$)
Table 108. CureVac Recent Development
Table 109. Stemirna Company Details
Table 110. Stemirna Business Overview
Table 111. Stemirna Product
Table 112. Company Description and Business Overview
Table 113. Stemirna mRNA Vaccines Product
Table 114. Stemirna Revenue in mRNA Vaccines Business 2019 and 2020 (Million US$)
Table 115. Stemirna Recent Development
Table 116. Company Description and Business Overview
Table 117. Company Description and Business Overview
Table 118. Company Description and Business Overview
Table 119. Company Description and Business Overview
Table 120. Company Description and Business Overview
Table 121. Company Description and Business Overview
Table 122. Company Description and Business Overview
Table 123. Company Description and Business Overview
Table 124. Company Description and Business Overview
Table 125. Company Description and Business Overview
Table 126. Company Description and Business Overview
Table 127. Company Description and Business Overview
Table 128. Company Description and Business Overview
Table 129. Company Description and Business Overview
Table 130. Company Description and Business Overview
Table 131. Company Description and Business Overview
Table 132. Company Description and Business Overview
Table 133. Company Description and Business Overview
Table 134. Company Description and Business Overview
Table 135. Company Description and Business Overview
Table 136. Company Description and Business Overview
Table 137. Company Description and Business Overview
Table 138. Company Description and Business Overview
Table 139. Company Description and Business Overview
Table 140. Company Description and Business Overview
Table 141. Company Description and Business Overview
Table 142. Company Description and Business Overview
Table 143. Company Description and Business Overview
Table 144. Company Description and Business Overview
Table 145. Company Description and Business Overview
Table 146. Company Description and Business Overview
Table 147. Company Description and Business Overview
Table 148. Company Description and Business Overview
Table 149. Company Description and Business Overview
Table 150. Key Drivers: Impact Analysis (2021-2026)
Table 151. Key Opportunities
Table 152. Key Challenges
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global mRNA Vaccines Market Share by Type: 2020 VS 2026
Figure 2. Being Developed Features
Figure 3. Preclinical Features
Figure 4. Clinical I Features
Figure 5. Clinical II Features
Figure 6. Global mRNA Vaccines Market Share by Application: 2020 VS 2026
Figure 7. COVID-19 Case Studies
Figure 8. Cancer Case Studies
Figure 9. Infectious Disease Treatment MRNA Vaccine Case Studies
Figure 10. Infection Prevention MRNA Vaccine Case Studies
Figure 11. mRNA Vaccines Report Years Considered
Figure 12. Global mRNA Vaccines and Growth Rate (2019-2026) (Million US$)
Figure 13. Global mRNA Vaccines Market Share by Regions (2019-2026)
Figure 14. Global mRNA Vaccines Market Share by Players in 2019
Figure 15. Global mRNA Vaccines Market Size Market Share by Type (2019-2026)
Figure 16. Global mRNA Vaccines Market Size Market Share by Application (2019-2026)
Figure 17. North America mRNA Vaccines Market Size YoY Growth (2019-2026) (Million US$)
Figure 18. Europe mRNA Vaccines Market Size YoY Growth (2019-2026) (Million US$)
Figure 19. China mRNA Vaccines Market Size YoY Growth (2019-2026) (Million US$)
Figure 20. Japan mRNA Vaccines Market Size YoY Growth (2019-2026) (Million US$)
Figure 21. Southeast Asia mRNA Vaccines Market Size YoY Growth (2019-2026) (Million US$)
Figure 22. India mRNA Vaccines Market Size YoY Growth (2019-2026) (Million US$)
Figure 23. Central & South America mRNA Vaccines Market Size YoY Growth (2019-2026) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 3900
$ 5850

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top